Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,730 recruiting studies in this area right now.
By phase
- Not applicable9,856
- Phase 24,487
- Phase 12,738
- Phase 1/Phase 21,696
- Phase 31,409
- Phase 2/Phase 3281
- Phase 4263
Top conditions
- Breast Cancer1,233
- Prostate Cancer660
- Cancer655
- Colorectal Cancer499
- Lung Cancer430
- Ovarian Cancer341
- Multiple Myeloma330
- Gastric Cancer302
- Pancreatic Cancer295
- Acute Myeloid Leukemia290
- Hepatocellular Carcinoma285
- Solid Tumor256
- Advanced Solid Tumor254
- Cervical Cancer233
- Head and Neck Cancer229
- Endometrial Cancer207
- Advanced Solid Tumors196
- Esophageal Cancer196
Leading sponsors
- M.D. Anderson Cancer Center452
- Fudan University317
- National Cancer Institute (NCI)291
- Sun Yat-sen University290
- Memorial Sloan Kettering Cancer Center289
- Mayo Clinic237
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center146
- AstraZeneca131
- University Health Network, Toronto125
Where studies are running
- California1,432
- Texas644
- Arizona514
- Florida437
- Alabama419
- New York410
- Massachusetts342
- Maryland331
- New Jersey267
- Pennsylvania237
Recruiting studies20,730 total
- NCT06590506Recruiting
Wearable health tracking for advanced solid tumor treatment
This trial studies how using a wearable device and smartphone app can help monitor your health during your first cancer treatment for advanced solid tumors. You will receive a known therapy (not a placebo), and the research team will collect real-world data to improve care.
A Coruña, A Coruña/ GaliciaAges 18 years+ - NCT06590727Recruiting
Emotional health in breast cancer patients
This study looks at how surgery or cancer treatments affect the emotional well-being of people with breast cancer. It aims to understand your feelings and mental health during treatment.
RomaAges 18 years+ - NCT06590766Recruiting
Acupuncture and massage for cancer patients in and after hospital
This trial studies whether adding acupuncture and hands-on therapies to standard care can improve quality of life for cancer patients. It starts in the hospital and continues as you transition back home.
Haifa, IsraelAges 18–100 - NCT06590948Recruiting
Using ultrasound features to classify liver nodules
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
Hangzhou, ZhejiangAges 18 years+ - NCT06591039Recruiting
Breast cancer patient study in China
This study follows people diagnosed with breast cancer to learn more about the disease and treatment. It may help improve future care.
Shanghai, Shanghai MunicipalityAges Any age - NCT06591819RecruitingPhase 2
Shorter pelvic radiation with HDR boost for prostate cancer
This trial tests a shorter course of radiation therapy (hypofractionated whole-pelvis radiation) combined with a high-dose-rate (HDR) brachytherapy boost for men with high-risk or unfavorable intermediate-risk prostate cancer. The goal is to see if this approach controls cancer while possibly reducing side effects.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06592170RecruitingPhase 1/Phase 2
Linperlisib and obinutuzumab for new MZL
This trial tests a combination of two drugs for people newly diagnosed with marginal zone lymphoma (MZL). The goal is to see if the combination works better than standard treatments.
Changchun, JilinAges 18 years+ - NCT06592326RecruitingPhase 3
Study of 9MW2821 with toripalimab vs chemo for advanced bladder cancer
This trial is testing a new combination of two drugs (9MW2821 and toripalimab) against standard chemotherapy for people with advanced bladder cancer that has not been treated before. The goal is to see if this new approach works better at shrinking tumors or slowing the cancer's growth.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06592638RecruitingPhase 1
ZG006 for small cell lung cancer
This trial tests a new drug called ZG006 for people with small cell lung cancer that has not responded to or can no longer tolerate standard treatments. The goal is to find the best dose and see if it can help shrink or control the cancer.
Orange, CaliforniaAges 18–75 - NCT06592573Recruiting
Anxiety and depression support for cancer caregivers
This trial tests whether online or in-person support can help reduce anxiety and depression symptoms in people caring for a loved one with cancer. You may be eligible if you're feeling anxious or down and are not currently in therapy.
Bologna, BOAges 18 years+ - NCT06592755Recruiting
New scar-free thyroid surgery vs. standard surgery for thyroid cancer
This trial compares a new, scar-free surgery (done through a small cut near the collarbone) to the standard open surgery for people with a common type of thyroid cancer. It may be a good option if your cancer is small and hasn't spread.
Guangzhou, GuangdongAges 18–70 - NCT06592599RecruitingPhase 2
Drug combo for EBV-related nasopharyngeal cancer
This trial tests a combination of three drugs (gemcitabine, docetaxel, and toripalimab) as a first treatment for a type of nasopharyngeal cancer linked to the Epstein-Barr virus. The goal is to see if this combination helps shrink tumors before other treatments like radiation.
Palo Alto, CaliforniaAges 18 years+ - NCT06592989Recruiting
Sorafenib and gefitinib for advanced pNET
This trial tests a combination of two targeted drugs (sorafenib and gefitinib) for people with pancreatic neuroendocrine tumors (pNETs) that have continued to grow after other treatments. The goal is to see if this combination can help control the tumor.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06593132Recruiting
Single-port endoscopic breast-conserving surgery trial
This trial compares a newer, less invasive endoscopic surgery (using a single small cut) to the traditional open surgery for removing breast cancer while keeping the breast. It's for women with early-stage breast cancer who want a breast-conserving option.
Xi'an, ShaanxiAges 20–70 - NCT06593145RecruitingPhase 1
CAR-T therapy for relapsed CD19+ B-cell cancers
This trial tests a new type of CAR-T cell therapy for people with certain B-cell cancers (leukemia or lymphoma) that have not responded to standard treatments. It aims to see if these specially engineered immune cells can attack and destroy the cancer.
Warsaw, Ul. Banacha 1aAges 18–65 - NCT06593665RecruitingPhase 3
Morphine in spine vs. IV methadone for testicular cancer surgery pain
This trial compares two ways to manage pain after surgery for testicular cancer: a single injection of morphine into the spine (intrathecal morphine) vs. methadone given through an IV during surgery. The goal is to see which provides better pain relief and fewer side effects.
Indianapolis, IndianaAges 18–80 - NCT06593639Recruiting
Prehabilitation for head and neck cancer patients
This study tests a prehabilitation program (exercise and nutrition support) to see if it helps patients with head and neck cancer who are about to start curative treatment. It aims to improve your strength and recovery before and during cancer therapy.
Naples, ItalyAges 18 years+ - NCT06593899RecruitingPhase 2
Chemotherapy and radiation before surgery for arm or leg sarcoma
This trial tests giving chemotherapy and radiation therapy together before surgery for soft tissue sarcoma in the arms or legs. The goal is to see if this approach can improve outcomes for people with larger, high-grade, or deep tumors.
Fuzhou, FujianAges 18–75 - NCT06593964Recruiting
TACE with a special gel vs standard beads for liver cancer
This trial compares a new gel-like treatment to standard beads for blocking the blood supply to liver tumors during TACE. It may be an option for patients with certain stages of liver cancer who cannot have surgery or other standard treatments.
NanjingAges 18–80 - NCT06594445RecruitingPhase 1
GTB-3650 TriKE for high-risk MDS and relapsed AML
This trial tests a new immunotherapy called GTB-3650 TriKE for people with high-risk MDS or AML that has come back or not responded to treatment. It aims to boost your immune system to fight the cancer.
Minneapolis, MinnesotaAges 18 years+ - NCT06594289Recruiting
Liver surgery trial with special blood flow control
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
Guangzhou, China/GuangdongAges 18–70 - NCT06594640RecruitingPhase 1/Phase 2
R-CMOP for newly diagnosed diffuse large B-cell lymphoma
This trial tests a new combination of drugs (R-CMOP) for people who have just been diagnosed with a type of lymphoma called diffuse large B-cell lymphoma (DLBCL) and have not yet received any treatment for it. The goal is to see if this treatment works well and is safe.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06594679RecruitingPhase 1/Phase 2
Study of niraparib and abemaciclib for advanced ovarian cancer
This trial tests a combination of two targeted drugs, niraparib and abemaciclib, for people with ovarian, fallopian tube, or primary peritoneal cancer that has come back after at least two prior chemotherapies. It may be an option if you have no standard treatments left and your cancer still responds to platinum-based chemotherapy.
Milan, MilanoAges 18 years+ - NCT06594744RecruitingPhase 4
Preventing first bleeding from varices in liver cancer patients
This trial compares two treatments (banding or a medication called carvedilol) to prevent the first episode of bleeding from enlarged veins in the esophagus in people with liver cancer. The goal is to find which approach is safer and more effective.
TaipeiAges 20–90
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,730 recruiting oncology studies from the U.S. registry right now, out of 32,266 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.